Targeting the Tumor Microenvironment with Lipid-Based Immunotherapies
The Bio Report - En podcast af Levine Media Group - Onsdage
Kategorier:
Don Wyatt, chief business officer for Highfield Biopharmaceuticals, discusses the tumor microenvironment, HighField’s platform technology, and how it is developing lipid-based medicines to overcome challenges of existing immunotherapies.
